INS and type 2 diabetes mellitus: The aims of this study are therefore to investigate the effectiveness and safety of a longer basal insulin, Gla‐300, in a real‐world setting to assist patients, clinicians and health care systems in making informed decisions on effective care and treatment for T2DM patients.